Taha Collaborative Industries Investment Co. (JSC) was established in 2006 in Sabzevar, Khorasan Razavi province, Iran. The company has more than 2000 shareholders and was inaugurated in 2016 with four separate production lines for API products by the Iranian Presidency.

It is the first unit producing the active ingredient of hormonal drugs in Iran and the 25th in the world. The semi-solid hormone drug production unit in this complex was launched in 2019.

Taha is currently delivering its products to the highest level of global pharmacopoeia standards, with specialist staffs in a deprived area and on the outskirts of the desert.